Riskpilot← Back to searchSign inGet full accessSIMED AS
ASActiveOrg 860425432Doktor Holms Vei 19D, 0787 OsloGeneral medical practice activities · NACE 8621Est. 19900 employees
Revenue 2024
NOK 3,7M
-5% vs 2023
EBITDA margin
48.1%
-27% vs 2023
Equity ratio
96.8%
Financial strength
Net profit 2024
NOK 2,2M
-31% vs 2023
| Revenue | NOK 3,7M | -5% |
| EBITDA | NOK 1,8M | -27% |
| Net profit | NOK 2,2M | -31% |
| Total assets | NOK 23,2M | +11% |
| Equity | NOK 22,4M | +11% |
| Employees | 0 | — |
Legal name
SIMED AS
Org number
860425432
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
4. desember 1990
Share capital
NOK 120 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selge medisinske tjenester inkl. Rådgivning om drift, utvikling, strategi m.v. Av enhver medisinsk orientert virksomhet. Selskapets formål er videre å eie og drive medisinsk klinikkvirksomhet som leverandør av helsetjenester og helserelaterte tjenester rettet mot private og offentlige personer og institusjoner. Selskapets formål er videre å drive investeringsvirksomhet og evt. Delta i drift og utvikling av de virksomheter det investeres i, herunder også fast eiendom.
Address
Doktor Holms Vei 19D, 0787 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 650 | 1 453 | 1 113 | 1 678 | 405 | 300 | 308 | 338 | 250 | 27 | 41 | 0 | 1 196 | 2 302 | 1 397 | 3 878 | 3 693 |
| Staff expenses | −0 | −765 | −302 | −864 | −916 | 61 | 15 | −0 | −0 | −0 | −0 | −0 | −0 | −763 | −91 | −512 | 199 | −0 |
| EBITDA | 0 | 1 947 | 302 | −80 | 689 | −291 | 155 | 961 | 293 | −322 | −124 | −139 | −202 | 242 | 677 | 454 | 2 422 | 1 776 |
| Depreciation & amort. | −0 | −149 | −119 | −95 | −76 | −61 | −49 | −39 | −31 | −20 | −16 | −13 | −10 | −48 | −8 | −8 | −0 | −0 |
| EBIT | 0 | 1 798 | 184 | −175 | 613 | −352 | 106 | 922 | 262 | −343 | −140 | −152 | −212 | 194 | 668 | 445 | 2 422 | 1 776 |
| Net financials | 0 | −8 | −564 | 23 | 587 | 260 | 1 404 | −1 030 | 513 | 1 668 | 21 218 | 1 261 | 1 921 | −4 828 | 142 | 159 | 1 066 | 1 081 |
| Profit before tax | 0 | 1 791 | −380 | −152 | 1 200 | −92 | 1 510 | −108 | 775 | 1 325 | 21 078 | 1 110 | 1 709 | −4 633 | 810 | 605 | 3 488 | 2 857 |
| Tax | −0 | 506 | −1 | −29 | 227 | 53 | 79 | −0 | 51 | 259 | −21 | −0 | −0 | 202 | 314 | −0 | 226 | 622 |
| Net profit | 0 | 1 285 | −379 | −123 | 973 | −145 | 1 432 | −108 | 724 | 1 066 | 21 099 | 1 110 | 1 709 | −4 836 | 496 | 605 | 3 262 | 2 235 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 9 760 | 9 038 | 9 057 | 10 248 | 9 475 | 40 312 | 45 805 | 46 548 | 48 589 | 32 337 | 32 447 | 34 180 | 26 156 | 27 205 | 17 401 | 20 937 | 23 184 |
| Equity | — | 9 040 | 8 811 | 8 688 | 9 661 | 8 616 | 9 465 | 9 357 | 10 081 | 11 147 | 32 246 | 32 356 | 34 064 | 25 129 | 15 630 | 16 941 | 20 203 | 22 438 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 30 000 | 36 266 | 36 331 | 36 249 | 91 | 91 | 91 | 14 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 719 | 107 | 279 | 496 | 859 | 847 | 183 | 136 | 1 194 | 0 | 0 | 25 | 1 012 | 11 575 | 460 | 734 | 746 |
| Total debt | 0 | 719 | 227 | 369 | 586 | 859 | 30 847 | 36 448 | 36 468 | 37 442 | 91 | 91 | 116 | 1 027 | 11 575 | 460 | 734 | 746 |
EBITDA margin
48.1%
This company
15.8%
Market median
+204% vs market
20072024
Equity ratio
96.8%
This company
38.2%
Market median
+153% vs market
20072024
Return on equity
10.0%
This company
18.4%
Market median
-46% vs market
20072024
Net profit margin
60.5%
This company
8.1%
Market median
+647% vs market
20072024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20072024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 7.5% | 7.5% | 2024 | |
| Individual | 7.5% | 7.5% | 2024 | |
| Individual | 7.5% | 7.5% | 2024 | |
| Individual | 7.5% | 7.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SIMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halfdan Vier Simensen | Chairman | 0 companies |
| Mona Kristin Hellund-Angerer | Board of Directors | 0 companies |